Zacks Investment Research
03 Apr 2026, 14:56 UTC · 29w ago
Verdict
Headline leans bullish. We score AVTX +0.80 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a mean short-term price target of $37.89 for Avalo Therapeutics (AVTX), implying a 113.3% upside from its recent close of $17.76.
So whatA consensus price target implying over 100% upside represents a significant bullish signal that could attract substantial retail and institutional buying interest if taken at face value.
More positive than 93% of claims this week
Analysts show strong agreement that Avalo Therapeutics will report earnings better than previously predicted, indicated by positive earnings estimate revisions.
Upward earnings estimate revisions are empirically linked to stock price appreciation and provide a fundamental basis for the bullish price targets, directly supporting risk appetite.
Continue reading
5 related stories
More positive than 90% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 86% of claims this week
Analyst price targets are frequently overly optimistic and unreliable predictors of actual stock direction, as analysts face conflicts of interest from investment banking relationships.
So whatHighlighting the systemic bias and unreliability of analyst price targets undermines the bullish signal of the 113% upside estimate, injecting significant skepticism that would temper investor risk appetite.
More negative than 86% of claims this week
The nine analyst price targets for AVTX have a standard deviation of $8.24, ranging from $24.00 to $50.00, reflecting high variability in estimates.
So whatA wide spread in price targets signals a lack of consensus on the company's valuation ceiling, adding uncertainty that reduces the reliability of the mean upside projection.
More negative than 70% of claims this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The stock shows a potential upside of 113.3% based on analyst price targets and positive earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
1d ago
−61.0%
Price is moving against the score
$6.93 vs $17.76 close before publication (Apr 2) · not market-adjusted
AVTX chart →
